Financings in Brief: Physician Sales & Service
This article was originally published in The Gray Sheet
Executive Summary
Physician Sales & Service: Medical supply distributor files registration statement with the Securities and Exchange Commission for an offering of 8.4 mil. shares of common including 2.4 mil. shares to be offered by selling shareholders. The number of offered shares reflects a three-for-one stock split effected Sept. 22 and distributed Oct. 5. Proceeds will go toward debt repayment "and for general corporate purposes, including possible future acquisitions," the Jacksonville, Florida-based firm states. PSS recently completed a stock-swap merger with Taylor Medical, a competitor in the physician supply market. The Taylor Medical merger was announced by PSS in April ("The Gray Sheet" April 17, In Brief). Alex. Brown & Sons, Smith Barney, Wheat First Butcher Singer, and Needham & Co. are managers for the offering...
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.